Terry J Fry

Summary

Affiliation: Children's National Medical Center
Country: USA

Publications

  1. doi request reprint Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 10010, USA
    Pediatr Clin North Am 55:147-67, xi. 2008
  2. doi request reprint The graft-versus-tumor effect in pediatric malignancy
    Terry J Fry
    Division of Blood and Marrow Transplantation Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 1 West Wing, 111 Michigan Avenue, NW, Washington, DC 20010, USA
    Pediatr Clin North Am 57:67-81. 2010
  3. doi request reprint Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 10010, USA
    Hematol Oncol Clin North Am 24:109-27. 2010
  4. doi request reprint Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis
    Ching Y Voss
    Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 20010, USA
    Transfus Med Rev 24:22-32. 2010
  5. doi request reprint Expanding options to improve outcomes following hematopoietic stem cell transplantation
    Terry J Fry
    Division of Blood and Marrow Transplantation, Children s National Medical Center, Washington, District of Columbia, USA
    Pediatr Blood Cancer 55:1043-4. 2010
  6. ncbi request reprint IL-7 in allogeneic transplant: clinical promise and potential pitfalls
    Kristen M Snyder
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethseda, MD 20892, USA
    Leuk Lymphoma 47:1222-8. 2006
  7. pmc Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
    Claude Sportes
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    J Exp Med 205:1701-14. 2008
  8. ncbi request reprint Cytokine signals in T-cell homeostasis
    Martin Guimond
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892 1104, USA
    J Immunother 28:289-94. 2005
  9. ncbi request reprint Escape from immune surveillance does not result in tolerance to tumor-associated antigens
    Fraia Melchionda
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    J Immunother 27:329-38. 2004
  10. ncbi request reprint Interleukin 7 worsens graft-versus-host disease
    Manoj L Sinha
    Pediatric Oncology Branch, Experimental Transplantation and Immunology Branch, National Cancer Institute, and Veterinary Resources Program, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 100:2642-9. 2002

Collaborators

Detail Information

Publications11

  1. doi request reprint Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 10010, USA
    Pediatr Clin North Am 55:147-67, xi. 2008
    ..In this article, we briefly provide a general overview of our current understanding of the immune system, with a focus on concepts in tumor immunology, followed by a discussion of how these concepts are being used in the clinic...
  2. doi request reprint The graft-versus-tumor effect in pediatric malignancy
    Terry J Fry
    Division of Blood and Marrow Transplantation Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 1 West Wing, 111 Michigan Avenue, NW, Washington, DC 20010, USA
    Pediatr Clin North Am 57:67-81. 2010
    ....
  3. doi request reprint Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology?
    Terry J Fry
    Division, Blood Marrow Transplantation and Immunology, Center for Cancer and Blood Disorders, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 10010, USA
    Hematol Oncol Clin North Am 24:109-27. 2010
    ..In this article, we briefly provide a general overview of our current understanding of the immune system, with a focus on concepts in tumor immunology, followed by a discussion of how these concepts are being used in the clinic...
  4. doi request reprint Extending the horizon for cell-based immunotherapy by understanding the mechanisms of action of photopheresis
    Ching Y Voss
    Center for Cancer and Blood Disorders, Children s National Medical Center, Washington, DC 20010, USA
    Transfus Med Rev 24:22-32. 2010
    ..Such immunotherapy interventions could bring significant clinical benefit to patients undergoing transplant rejection or autoimmune-related disorders and deserve further investigation as well as validation studies...
  5. doi request reprint Expanding options to improve outcomes following hematopoietic stem cell transplantation
    Terry J Fry
    Division of Blood and Marrow Transplantation, Children s National Medical Center, Washington, District of Columbia, USA
    Pediatr Blood Cancer 55:1043-4. 2010
    ..However, the risk of treatment-related mortality remains approximately 5-10%, in part due to complications such as veno-occlusive disease (VOD) for which there has been less progress...
  6. ncbi request reprint IL-7 in allogeneic transplant: clinical promise and potential pitfalls
    Kristen M Snyder
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethseda, MD 20892, USA
    Leuk Lymphoma 47:1222-8. 2006
    ..Thus, careful consideration of how best to incorporate IL-7 into allogeneic trials will be needed if the full potential of this agent is to be realized...
  7. pmc Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets
    Claude Sportes
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA
    J Exp Med 205:1701-14. 2008
    ....
  8. ncbi request reprint Cytokine signals in T-cell homeostasis
    Martin Guimond
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892 1104, USA
    J Immunother 28:289-94. 2005
    ....
  9. ncbi request reprint Escape from immune surveillance does not result in tolerance to tumor-associated antigens
    Fraia Melchionda
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA
    J Immunother 27:329-38. 2004
    ....
  10. ncbi request reprint Interleukin 7 worsens graft-versus-host disease
    Manoj L Sinha
    Pediatric Oncology Branch, Experimental Transplantation and Immunology Branch, National Cancer Institute, and Veterinary Resources Program, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 100:2642-9. 2002
    ..These results suggest that use of IL-7 should be limited to the setting of TCD BMT to obtain the greatest benefit on immune competence with the least toxicity...
  11. ncbi request reprint Current concepts of thymic aging
    Terry J Fry
    Pediatric Oncology Branch, National Cancer Institute, Bldg 10, Rm 13N240, 10 Center Dr MSC 1928, Bethesda, MD 20892 1928, USA
    Springer Semin Immunopathol 24:7-22. 2002